Literature DB >> 15386323

Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A.

H Gibelin1, S Bezieau, C Misso, M-H Bouin-Pineau, R Maréchaud, J-L Kraimps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15386323     DOI： 10.1002/bjs.4718

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  7 in total

1.  Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

Authors:  Thereasa A Rich; Lei Feng; Naifa Busaidy; Gilbert J Cote; Robert F Gagel; Mimi Hu; Camilo Jimenez; Jeffrey E Lee; Nancy Perrier; Steven I Sherman; Steven G Waguespack; Anita Ying; Elizabeth Grubbs
Journal:  Thyroid       Date:  2014-06-06       Impact factor: 6.568

Review 2.  Controversy on the management of patients carrying RET p.V804M mutation.

Authors:  Ali S Alzahrani; Meshael Alswailem; Balgees Alghamdi; Rafiullah Rafiullah; Mohammed Aldawish; Hindi Al-Hindi
Journal:  Endocrine       Date:  2021-10-12       Impact factor: 3.633

3.  Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.

Authors:  Iván Plaza-Menacho; Karin Barnouin; Kerry Goodman; Rubén J Martínez-Torres; Annabel Borg; Judith Murray-Rust; Stephane Mouilleron; Phillip Knowles; Neil Q McDonald
Journal:  Mol Cell       Date:  2014-02-20       Impact factor: 17.970

4.  Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline.

Authors:  Danielle M Pendrick; Jennifer A Oberg; Susan J Hsiao; Wendy K Chung; Carrie Koval; Anthony Sireci; Jennifer H Kuo; Prakash Satwani; Chana L Glasser; Maria Luisa Sulis; Mahesh M Mansukhani; Julia L Glade Bender
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-04-01

5.  A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation.

Authors:  Young Sik Choi; Hye Jung Kwon; Bu Kyung Kim; Su Kyoung Kwon; Yo Han Park; Jeong Hoon Kim; Sang Bong Jung; Chang Hoon Lee; Seong Keun Lee; Shinya Uchino
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

6.  The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association.

Authors:  Laura Fugazzola; Simone De Leo; Michela Perrino
Journal:  Thyroid Res       Date:  2013-03-14

7.  Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.

Authors:  Margarita Raygada; Mark Raffeld; Andrew Bernstein; Markku Miettinen; John Glod; Marybeth S Hughes; Karlyne Reilly; Brigitte Widemann; Jaydira Del Rivero
Journal:  Am J Med Genet A       Date:  2021-02-21       Impact factor: 2.802
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.